nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—NR3C1—epilepsy syndrome	0.534	1	CbGaD
Cyproterone acetate—Megestrol acetate—NR3C1—epilepsy syndrome	0.00082	0.484	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—NR3C1—epilepsy syndrome	0.000477	0.282	CrCbGaD
Cyproterone acetate—Megestrol acetate—ABCB1—epilepsy syndrome	0.000395	0.234	CrCbGaD
Cyproterone acetate—NR3C1—hindbrain—epilepsy syndrome	0.000351	0.0882	CbGeAlD
Cyproterone acetate—CYP19A1—forebrain—epilepsy syndrome	0.000303	0.0761	CbGeAlD
Cyproterone acetate—AR—forebrain—epilepsy syndrome	0.000268	0.0674	CbGeAlD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	0.000251	0.00373	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CDC42—epilepsy syndrome	0.000249	0.0037	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.000247	0.00367	CbGpPWpGaD
Cyproterone acetate—AR—telencephalon—epilepsy syndrome	0.000247	0.062	CbGeAlD
Cyproterone acetate—NR3C1—Circadian Clock—MEF2C—epilepsy syndrome	0.000245	0.00365	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—SRC—epilepsy syndrome	0.00024	0.00357	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	0.000237	0.00353	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—SIRT1—epilepsy syndrome	0.000236	0.00351	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	0.000234	0.00348	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	0.000234	0.00348	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAZ—epilepsy syndrome	0.000232	0.00345	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—SRC—epilepsy syndrome	0.000231	0.00343	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—epilepsy syndrome	0.000226	0.00336	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.000224	0.00333	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.000222	0.0033	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.000222	0.0033	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.000215	0.0032	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.000215	0.0032	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TSC1—epilepsy syndrome	0.000214	0.00318	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CASP8—epilepsy syndrome	0.000212	0.00315	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—BMP4—epilepsy syndrome	0.000209	0.00311	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.000209	0.0031	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.000208	0.0031	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.000203	0.00301	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.000203	0.00301	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—JUN—epilepsy syndrome	0.000202	0.003	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.000202	0.003	CbGpPWpGaD
Cyproterone acetate—NR3C1—brainstem—epilepsy syndrome	0.000201	0.0506	CbGeAlD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—epilepsy syndrome	0.0002	0.00297	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—epilepsy syndrome	0.000194	0.00289	CbGpPWpGaD
Cyproterone acetate—NR3C1—forebrain—epilepsy syndrome	0.000194	0.0488	CbGeAlD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	0.00019	0.00283	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	0.000189	0.00281	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.000187	0.00278	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.000186	0.00276	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2C19—epilepsy syndrome	0.000185	0.00275	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TSC1—epilepsy syndrome	0.000184	0.00274	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP11A1—epilepsy syndrome	0.000184	0.00273	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.000182	0.00271	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.000181	0.00269	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	0.00018	0.00268	CbGpPWpGaD
Cyproterone acetate—NR3C1—telencephalon—epilepsy syndrome	0.000179	0.0449	CbGeAlD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—AGT—epilepsy syndrome	0.000175	0.0026	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	0.000174	0.00259	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PLAU—epilepsy syndrome	0.000174	0.00258	CbGpPWpGaD
Cyproterone acetate—CYP19A1—head—epilepsy syndrome	0.000173	0.0436	CbGeAlD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	0.000173	0.00257	CbGpPWpGaD
Cyproterone acetate—AR—spinal cord—epilepsy syndrome	0.000173	0.0434	CbGeAlD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.00017	0.00253	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2D6—epilepsy syndrome	0.000166	0.00247	CbGpPWpGaD
Cyproterone acetate—CYP19A1—nervous system—epilepsy syndrome	0.000164	0.0413	CbGeAlD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.000164	0.00243	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.000163	0.00243	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDC42—epilepsy syndrome	0.000163	0.00242	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	0.000159	0.00237	CbGpPWpGaD
Cyproterone acetate—CYP19A1—central nervous system—epilepsy syndrome	0.000158	0.0398	CbGeAlD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.000158	0.00235	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	0.000156	0.00232	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—SIRT1—epilepsy syndrome	0.000155	0.0023	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.000154	0.00229	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.000154	0.00229	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.000154	0.00228	CbGpPWpGaD
Cyproterone acetate—AR—head—epilepsy syndrome	0.000154	0.0386	CbGeAlD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.000153	0.00228	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	0.000153	0.00227	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.000151	0.00225	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.000149	0.00222	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—AKT1—epilepsy syndrome	0.000149	0.00222	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—FOS—epilepsy syndrome	0.000147	0.00219	CbGpPWpGaD
Cyproterone acetate—AR—nervous system—epilepsy syndrome	0.000146	0.0366	CbGeAlD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.000145	0.00216	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCL2—epilepsy syndrome	0.000144	0.00214	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.000144	0.00214	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AKT1—epilepsy syndrome	0.000143	0.00213	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—WARS—epilepsy syndrome	0.000143	0.00213	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.000141	0.0021	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.000141	0.00209	CbGpPWpGaD
Cyproterone acetate—NR3C1—medulla oblongata—epilepsy syndrome	0.00014	0.0353	CbGeAlD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDC42—epilepsy syndrome	0.00014	0.00208	CbGpPWpGaD
Cyproterone acetate—AR—central nervous system—epilepsy syndrome	0.00014	0.0352	CbGeAlD
Cyproterone acetate—NR3C1—Adipogenesis—SOCS3—epilepsy syndrome	0.00014	0.00208	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.000136	0.00202	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.000134	0.002	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	0.000134	0.00199	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—epilepsy syndrome	0.000133	0.00198	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	0.000132	0.00196	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—RELA—epilepsy syndrome	0.000131	0.00195	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	0.000131	0.00195	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.00013	0.00194	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—FOS—epilepsy syndrome	0.00013	0.00193	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—POMC—epilepsy syndrome	0.00013	0.00193	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	0.000129	0.00191	CbGpPWpGaD
Cyproterone acetate—NR3C1—midbrain—epilepsy syndrome	0.000128	0.0322	CbGeAlD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	0.000128	0.00191	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.000128	0.0019	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	0.000127	0.00188	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CA13—epilepsy syndrome	0.000126	0.00188	CbGpPWpGaD
Cyproterone acetate—CYP19A1—brain—epilepsy syndrome	0.000126	0.0316	CbGeAlD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—epilepsy syndrome	0.000125	0.00186	CbGpPWpGaD
Cyproterone acetate—NR3C1—spinal cord—epilepsy syndrome	0.000125	0.0314	CbGeAlD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	0.000125	0.00185	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	0.000124	0.00184	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—MEF2C—epilepsy syndrome	0.000123	0.00183	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—epilepsy syndrome	0.000122	0.00181	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	0.000119	0.00176	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	0.000117	0.00175	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.000117	0.00173	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—JUN—epilepsy syndrome	0.000115	0.00171	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.000115	0.00171	CbGpPWpGaD
Cyproterone acetate—AR—brain—epilepsy syndrome	0.000111	0.028	CbGeAlD
Cyproterone acetate—NR3C1—head—epilepsy syndrome	0.000111	0.0279	CbGeAlD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.00011	0.00164	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—WARS—epilepsy syndrome	0.000109	0.00162	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—QARS—epilepsy syndrome	0.000109	0.00161	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	0.000107	0.00159	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.000107	0.00159	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—AGT—epilepsy syndrome	0.000106	0.00158	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—RELA—epilepsy syndrome	0.000106	0.00158	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—JUN—epilepsy syndrome	0.000106	0.00157	CbGpPWpGaD
Cyproterone acetate—NR3C1—nervous system—epilepsy syndrome	0.000105	0.0265	CbGeAlD
Cyproterone acetate—AR—Androgen receptor signaling pathway—SRC—epilepsy syndrome	0.000103	0.00153	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.000103	0.00153	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—epilepsy syndrome	0.000103	0.00153	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	0.000103	0.00152	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.000102	0.00151	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.000102	0.00151	CbGpPWpGaD
Cyproterone acetate—NR3C1—central nervous system—epilepsy syndrome	0.000101	0.0255	CbGeAlD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	0.000101	0.0015	CbGpPWpGaD
Cyproterone acetate—NR3C1—cerebellum—epilepsy syndrome	9.92e-05	0.0249	CbGeAlD
Cyproterone acetate—Malnutrition—Gabapentin—epilepsy syndrome	9.87e-05	0.000251	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Clonazepam—epilepsy syndrome	9.83e-05	0.00025	CcSEcCtD
Cyproterone acetate—Dizziness—Vigabatrin—epilepsy syndrome	9.81e-05	0.00025	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IL6ST—epilepsy syndrome	9.8e-05	0.00146	CbGpPWpGaD
Cyproterone acetate—Pruritus—Zonisamide—epilepsy syndrome	9.79e-05	0.000249	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Phenytoin—epilepsy syndrome	9.76e-05	0.000249	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	9.73e-05	0.00145	CbGpPWpGaD
Cyproterone acetate—Oedema—Valproic Acid—epilepsy syndrome	9.71e-05	0.000247	CcSEcCtD
Cyproterone acetate—Urticaria—Lamotrigine—epilepsy syndrome	9.71e-05	0.000247	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.71e-05	0.000247	CcSEcCtD
Cyproterone acetate—Malaise—Pregabalin—epilepsy syndrome	9.7e-05	0.000247	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	9.7e-05	0.00144	CbGpPWpGaD
Cyproterone acetate—Nausea—Propofol—epilepsy syndrome	9.7e-05	0.000247	CcSEcCtD
Cyproterone acetate—Tension—Gabapentin—epilepsy syndrome	9.68e-05	0.000247	CcSEcCtD
Cyproterone acetate—Vomiting—Fosphenytoin—epilepsy syndrome	9.68e-05	0.000247	CcSEcCtD
Cyproterone acetate—Diarrhoea—Felbamate—epilepsy syndrome	9.68e-05	0.000246	CcSEcCtD
Cyproterone acetate—Body temperature increased—Lamotrigine—epilepsy syndrome	9.66e-05	0.000246	CcSEcCtD
Cyproterone acetate—Abdominal pain—Lamotrigine—epilepsy syndrome	9.66e-05	0.000246	CcSEcCtD
Cyproterone acetate—Dizziness—Diazepam—epilepsy syndrome	9.66e-05	0.000246	CcSEcCtD
Cyproterone acetate—Syncope—Pregabalin—epilepsy syndrome	9.65e-05	0.000246	CcSEcCtD
Cyproterone acetate—Leukopenia—Pregabalin—epilepsy syndrome	9.63e-05	0.000245	CcSEcCtD
Cyproterone acetate—Rash—Fosphenytoin—epilepsy syndrome	9.6e-05	0.000245	CcSEcCtD
Cyproterone acetate—Dermatitis—Fosphenytoin—epilepsy syndrome	9.59e-05	0.000244	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—FAR1—epilepsy syndrome	9.59e-05	0.00143	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—L2HGDH—epilepsy syndrome	9.59e-05	0.00143	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADK—epilepsy syndrome	9.59e-05	0.00143	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GLUD1—epilepsy syndrome	9.59e-05	0.00143	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CERS1—epilepsy syndrome	9.59e-05	0.00143	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PDXK—epilepsy syndrome	9.59e-05	0.00143	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Topiramate—epilepsy syndrome	9.58e-05	0.000244	CcSEcCtD
Cyproterone acetate—Asthenia—Clonazepam—epilepsy syndrome	9.57e-05	0.000244	CcSEcCtD
Cyproterone acetate—Headache—Fosphenytoin—epilepsy syndrome	9.54e-05	0.000243	CcSEcCtD
Cyproterone acetate—Hepatitis—Topiramate—epilepsy syndrome	9.54e-05	0.000243	CcSEcCtD
Cyproterone acetate—Haemorrhage—Topiramate—epilepsy syndrome	9.54e-05	0.000243	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Valproic Acid—epilepsy syndrome	9.53e-05	0.000243	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Valproic Acid—epilepsy syndrome	9.51e-05	0.000242	CcSEcCtD
Cyproterone acetate—Asthenia—Phenytoin—epilepsy syndrome	9.51e-05	0.000242	CcSEcCtD
Cyproterone acetate—Nausea—Midazolam—epilepsy syndrome	9.49e-05	0.000242	CcSEcCtD
Cyproterone acetate—Tachycardia—Valproic Acid—epilepsy syndrome	9.48e-05	0.000241	CcSEcCtD
Cyproterone acetate—Diarrhoea—Zonisamide—epilepsy syndrome	9.47e-05	0.000241	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Pregabalin—epilepsy syndrome	9.46e-05	0.000241	CcSEcCtD
Cyproterone acetate—Asthenia—Oxcarbazepine—epilepsy syndrome	9.46e-05	0.000241	CcSEcCtD
Cyproterone acetate—Pruritus—Clonazepam—epilepsy syndrome	9.44e-05	0.00024	CcSEcCtD
Cyproterone acetate—Vomiting—Vigabatrin—epilepsy syndrome	9.44e-05	0.00024	CcSEcCtD
Cyproterone acetate—Skin disorder—Valproic Acid—epilepsy syndrome	9.44e-05	0.00024	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	9.41e-05	0.0014	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.39e-05	0.000239	CcSEcCtD
Cyproterone acetate—Cough—Pregabalin—epilepsy syndrome	9.39e-05	0.000239	CcSEcCtD
Cyproterone acetate—Pruritus—Phenytoin—epilepsy syndrome	9.38e-05	0.000239	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Topiramate—epilepsy syndrome	9.37e-05	0.000239	CcSEcCtD
Cyproterone acetate—Nausea—Levetiracetam—epilepsy syndrome	9.37e-05	0.000239	CcSEcCtD
Cyproterone acetate—Rash—Vigabatrin—epilepsy syndrome	9.36e-05	0.000238	CcSEcCtD
Cyproterone acetate—Dizziness—Felbamate—epilepsy syndrome	9.35e-05	0.000238	CcSEcCtD
Cyproterone acetate—Dermatitis—Vigabatrin—epilepsy syndrome	9.35e-05	0.000238	CcSEcCtD
Cyproterone acetate—Pruritus—Oxcarbazepine—epilepsy syndrome	9.33e-05	0.000238	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.32e-05	0.000237	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—JUN—epilepsy syndrome	9.32e-05	0.00139	CbGpPWpGaD
Cyproterone acetate—Headache—Vigabatrin—epilepsy syndrome	9.3e-05	0.000237	CcSEcCtD
Cyproterone acetate—Vomiting—Diazepam—epilepsy syndrome	9.29e-05	0.000237	CcSEcCtD
Cyproterone acetate—Anorexia—Valproic Acid—epilepsy syndrome	9.26e-05	0.000236	CcSEcCtD
Cyproterone acetate—Rash—Diazepam—epilepsy syndrome	9.21e-05	0.000235	CcSEcCtD
Cyproterone acetate—Dermatitis—Diazepam—epilepsy syndrome	9.2e-05	0.000234	CcSEcCtD
Cyproterone acetate—Visual impairment—Topiramate—epilepsy syndrome	9.19e-05	0.000234	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Gabapentin—epilepsy syndrome	9.16e-05	0.000233	CcSEcCtD
Cyproterone acetate—Dizziness—Zonisamide—epilepsy syndrome	9.15e-05	0.000233	CcSEcCtD
Cyproterone acetate—Headache—Diazepam—epilepsy syndrome	9.15e-05	0.000233	CcSEcCtD
Cyproterone acetate—Diarrhoea—Clonazepam—epilepsy syndrome	9.13e-05	0.000233	CcSEcCtD
Cyproterone acetate—Anaemia—Gabapentin—epilepsy syndrome	9.12e-05	0.000232	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.1e-05	0.000232	CcSEcCtD
Cyproterone acetate—Hypotension—Valproic Acid—epilepsy syndrome	9.08e-05	0.000231	CcSEcCtD
Cyproterone acetate—Asthenia—Carbamazepine—epilepsy syndrome	9.08e-05	0.000231	CcSEcCtD
Cyproterone acetate—Agitation—Gabapentin—epilepsy syndrome	9.07e-05	0.000231	CcSEcCtD
Cyproterone acetate—Diarrhoea—Phenytoin—epilepsy syndrome	9.07e-05	0.000231	CcSEcCtD
Cyproterone acetate—Discomfort—Pregabalin—epilepsy syndrome	9.05e-05	0.000231	CcSEcCtD
Cyproterone acetate—Nausea—Fosphenytoin—epilepsy syndrome	9.04e-05	0.00023	CcSEcCtD
Cyproterone acetate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.02e-05	0.00023	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Topiramate—epilepsy syndrome	9.02e-05	0.00023	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.01e-05	0.000229	CcSEcCtD
Cyproterone acetate—Vomiting—Felbamate—epilepsy syndrome	8.99e-05	0.000229	CcSEcCtD
Cyproterone acetate—Pruritus—Carbamazepine—epilepsy syndrome	8.95e-05	0.000228	CcSEcCtD
Cyproterone acetate—Rash—Felbamate—epilepsy syndrome	8.92e-05	0.000227	CcSEcCtD
Cyproterone acetate—Eye disorder—Topiramate—epilepsy syndrome	8.91e-05	0.000227	CcSEcCtD
Cyproterone acetate—Dermatitis—Felbamate—epilepsy syndrome	8.91e-05	0.000227	CcSEcCtD
Cyproterone acetate—Malaise—Gabapentin—epilepsy syndrome	8.9e-05	0.000227	CcSEcCtD
Cyproterone acetate—Headache—Felbamate—epilepsy syndrome	8.86e-05	0.000226	CcSEcCtD
Cyproterone acetate—Syncope—Gabapentin—epilepsy syndrome	8.85e-05	0.000225	CcSEcCtD
Cyproterone acetate—Leukopenia—Gabapentin—epilepsy syndrome	8.83e-05	0.000225	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	8.82e-05	0.00131	CbGpPWpGaD
Cyproterone acetate—Dizziness—Clonazepam—epilepsy syndrome	8.82e-05	0.000225	CcSEcCtD
Cyproterone acetate—Nausea—Vigabatrin—epilepsy syndrome	8.82e-05	0.000225	CcSEcCtD
Cyproterone acetate—Vomiting—Zonisamide—epilepsy syndrome	8.8e-05	0.000224	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	8.8e-05	0.00131	CbGpPWpGaD
Cyproterone acetate—Oedema—Pregabalin—epilepsy syndrome	8.78e-05	0.000224	CcSEcCtD
Cyproterone acetate—Asthenia—Lamotrigine—epilepsy syndrome	8.77e-05	0.000223	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—NHLRC1—epilepsy syndrome	8.77e-05	0.0013	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GAMT—epilepsy syndrome	8.77e-05	0.0013	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—EPM2A—epilepsy syndrome	8.77e-05	0.0013	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PNPO—epilepsy syndrome	8.77e-05	0.0013	CbGpPWpGaD
Cyproterone acetate—Dizziness—Phenytoin—epilepsy syndrome	8.76e-05	0.000223	CcSEcCtD
Cyproterone acetate—Rash—Zonisamide—epilepsy syndrome	8.73e-05	0.000222	CcSEcCtD
Cyproterone acetate—Dermatitis—Zonisamide—epilepsy syndrome	8.72e-05	0.000222	CcSEcCtD
Cyproterone acetate—Dizziness—Oxcarbazepine—epilepsy syndrome	8.72e-05	0.000222	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—EIF2B5—epilepsy syndrome	8.68e-05	0.00129	CbGpPWpGaD
Cyproterone acetate—Nausea—Diazepam—epilepsy syndrome	8.68e-05	0.000221	CcSEcCtD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—epilepsy syndrome	8.67e-05	0.00129	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Gabapentin—epilepsy syndrome	8.67e-05	0.000221	CcSEcCtD
Cyproterone acetate—Headache—Zonisamide—epilepsy syndrome	8.67e-05	0.000221	CcSEcCtD
Cyproterone acetate—Dyspnoea—Valproic Acid—epilepsy syndrome	8.66e-05	0.000221	CcSEcCtD
Cyproterone acetate—Diarrhoea—Carbamazepine—epilepsy syndrome	8.65e-05	0.00022	CcSEcCtD
Cyproterone acetate—Angiopathy—Topiramate—epilepsy syndrome	8.65e-05	0.00022	CcSEcCtD
Cyproterone acetate—Pruritus—Lamotrigine—epilepsy syndrome	8.65e-05	0.00022	CcSEcCtD
Cyproterone acetate—Shock—Pregabalin—epilepsy syndrome	8.64e-05	0.00022	CcSEcCtD
Cyproterone acetate—Immune system disorder—Topiramate—epilepsy syndrome	8.61e-05	0.000219	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Pregabalin—epilepsy syndrome	8.61e-05	0.000219	CcSEcCtD
Cyproterone acetate—Cough—Gabapentin—epilepsy syndrome	8.61e-05	0.000219	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Pregabalin—epilepsy syndrome	8.6e-05	0.000219	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Topiramate—epilepsy syndrome	8.59e-05	0.000219	CcSEcCtD
Cyproterone acetate—Tachycardia—Pregabalin—epilepsy syndrome	8.57e-05	0.000218	CcSEcCtD
Cyproterone acetate—Chills—Topiramate—epilepsy syndrome	8.56e-05	0.000218	CcSEcCtD
Cyproterone acetate—Dyspepsia—Valproic Acid—epilepsy syndrome	8.55e-05	0.000218	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	8.55e-05	0.00127	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Pregabalin—epilepsy syndrome	8.53e-05	0.000217	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	8.5e-05	0.00126	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.49e-05	0.000216	CcSEcCtD
Cyproterone acetate—Vomiting—Clonazepam—epilepsy syndrome	8.48e-05	0.000216	CcSEcCtD
Cyproterone acetate—Decreased appetite—Valproic Acid—epilepsy syndrome	8.44e-05	0.000215	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	8.44e-05	0.00125	CbGpPWpGaD
Cyproterone acetate—Alopecia—Topiramate—epilepsy syndrome	8.43e-05	0.000215	CcSEcCtD
Cyproterone acetate—Vomiting—Phenytoin—epilepsy syndrome	8.43e-05	0.000215	CcSEcCtD
Cyproterone acetate—Rash—Clonazepam—epilepsy syndrome	8.41e-05	0.000214	CcSEcCtD
Cyproterone acetate—Dermatitis—Clonazepam—epilepsy syndrome	8.4e-05	0.000214	CcSEcCtD
Cyproterone acetate—Nausea—Felbamate—epilepsy syndrome	8.4e-05	0.000214	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.39e-05	0.000214	CcSEcCtD
Cyproterone acetate—Vomiting—Oxcarbazepine—epilepsy syndrome	8.38e-05	0.000213	CcSEcCtD
Cyproterone acetate—Fatigue—Valproic Acid—epilepsy syndrome	8.38e-05	0.000213	CcSEcCtD
Cyproterone acetate—Anorexia—Pregabalin—epilepsy syndrome	8.37e-05	0.000213	CcSEcCtD
Cyproterone acetate—Dizziness—Carbamazepine—epilepsy syndrome	8.36e-05	0.000213	CcSEcCtD
Cyproterone acetate—Diarrhoea—Lamotrigine—epilepsy syndrome	8.36e-05	0.000213	CcSEcCtD
Cyproterone acetate—Headache—Clonazepam—epilepsy syndrome	8.36e-05	0.000213	CcSEcCtD
Cyproterone acetate—Rash—Phenytoin—epilepsy syndrome	8.36e-05	0.000213	CcSEcCtD
Cyproterone acetate—Mental disorder—Topiramate—epilepsy syndrome	8.35e-05	0.000213	CcSEcCtD
Cyproterone acetate—Dermatitis—Phenytoin—epilepsy syndrome	8.35e-05	0.000213	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.34e-05	0.000213	CcSEcCtD
Cyproterone acetate—Rash—Oxcarbazepine—epilepsy syndrome	8.31e-05	0.000212	CcSEcCtD
Cyproterone acetate—Constipation—Valproic Acid—epilepsy syndrome	8.31e-05	0.000212	CcSEcCtD
Cyproterone acetate—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.3e-05	0.000212	CcSEcCtD
Cyproterone acetate—Headache—Phenytoin—epilepsy syndrome	8.3e-05	0.000211	CcSEcCtD
Cyproterone acetate—Malnutrition—Topiramate—epilepsy syndrome	8.3e-05	0.000211	CcSEcCtD
Cyproterone acetate—Discomfort—Gabapentin—epilepsy syndrome	8.3e-05	0.000211	CcSEcCtD
Cyproterone acetate—Headache—Oxcarbazepine—epilepsy syndrome	8.26e-05	0.00021	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—QARS—epilepsy syndrome	8.24e-05	0.00122	CbGpPWpGaD
Cyproterone acetate—Nausea—Zonisamide—epilepsy syndrome	8.22e-05	0.000209	CcSEcCtD
Cyproterone acetate—Hypotension—Pregabalin—epilepsy syndrome	8.21e-05	0.000209	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CA4—epilepsy syndrome	8.15e-05	0.00121	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—QDPR—epilepsy syndrome	8.15e-05	0.00121	CbGpPWpGaD
Cyproterone acetate—Tension—Topiramate—epilepsy syndrome	8.15e-05	0.000208	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—POMC—epilepsy syndrome	8.13e-05	0.00121	CbGpPWpGaD
Cyproterone acetate—Dizziness—Lamotrigine—epilepsy syndrome	8.08e-05	0.000206	CcSEcCtD
Cyproterone acetate—NR3C1—brain—epilepsy syndrome	8.06e-05	0.0203	CbGeAlD
Cyproterone acetate—Oedema—Gabapentin—epilepsy syndrome	8.05e-05	0.000205	CcSEcCtD
Cyproterone acetate—Vomiting—Carbamazepine—epilepsy syndrome	8.04e-05	0.000205	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.01e-05	0.000204	CcSEcCtD
Cyproterone acetate—Rash—Carbamazepine—epilepsy syndrome	7.98e-05	0.000203	CcSEcCtD
Cyproterone acetate—Dermatitis—Carbamazepine—epilepsy syndrome	7.97e-05	0.000203	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.94e-05	0.000202	CcSEcCtD
Cyproterone acetate—Nausea—Clonazepam—epilepsy syndrome	7.92e-05	0.000202	CcSEcCtD
Cyproterone acetate—Headache—Carbamazepine—epilepsy syndrome	7.92e-05	0.000202	CcSEcCtD
Cyproterone acetate—Shock—Gabapentin—epilepsy syndrome	7.92e-05	0.000202	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—JUNB—epilepsy syndrome	7.9e-05	0.00118	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Gabapentin—epilepsy syndrome	7.9e-05	0.000201	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Gabapentin—epilepsy syndrome	7.88e-05	0.000201	CcSEcCtD
Cyproterone acetate—Nausea—Phenytoin—epilepsy syndrome	7.87e-05	0.0002	CcSEcCtD
Cyproterone acetate—Tachycardia—Gabapentin—epilepsy syndrome	7.86e-05	0.0002	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—TFAM—epilepsy syndrome	7.85e-05	0.00117	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Pregabalin—epilepsy syndrome	7.83e-05	0.000199	CcSEcCtD
Cyproterone acetate—Nausea—Oxcarbazepine—epilepsy syndrome	7.83e-05	0.000199	CcSEcCtD
Cyproterone acetate—Skin disorder—Gabapentin—epilepsy syndrome	7.82e-05	0.000199	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.79e-05	0.000198	CcSEcCtD
Cyproterone acetate—Vomiting—Lamotrigine—epilepsy syndrome	7.77e-05	0.000198	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	7.76e-05	0.00115	CbGpPWpGaD
Cyproterone acetate—Urticaria—Valproic Acid—epilepsy syndrome	7.72e-05	0.000197	CcSEcCtD
Cyproterone acetate—Rash—Lamotrigine—epilepsy syndrome	7.71e-05	0.000196	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Topiramate—epilepsy syndrome	7.7e-05	0.000196	CcSEcCtD
Cyproterone acetate—Dermatitis—Lamotrigine—epilepsy syndrome	7.7e-05	0.000196	CcSEcCtD
Cyproterone acetate—Body temperature increased—Valproic Acid—epilepsy syndrome	7.68e-05	0.000196	CcSEcCtD
Cyproterone acetate—Abdominal pain—Valproic Acid—epilepsy syndrome	7.68e-05	0.000196	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	7.68e-05	0.00114	CbGpPWpGaD
Cyproterone acetate—Anorexia—Gabapentin—epilepsy syndrome	7.68e-05	0.000196	CcSEcCtD
Cyproterone acetate—Anaemia—Topiramate—epilepsy syndrome	7.67e-05	0.000195	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—COX3—epilepsy syndrome	7.66e-05	0.00114	CbGpPWpGaD
Cyproterone acetate—Headache—Lamotrigine—epilepsy syndrome	7.66e-05	0.000195	CcSEcCtD
Cyproterone acetate—Decreased appetite—Pregabalin—epilepsy syndrome	7.63e-05	0.000194	CcSEcCtD
Cyproterone acetate—Agitation—Topiramate—epilepsy syndrome	7.63e-05	0.000194	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.58e-05	0.000193	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	7.58e-05	0.00113	CbGpPWpGaD
Cyproterone acetate—Fatigue—Pregabalin—epilepsy syndrome	7.57e-05	0.000193	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	7.57e-05	0.00113	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	7.56e-05	0.00112	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	7.54e-05	0.00112	CbGpPWpGaD
Cyproterone acetate—Hypotension—Gabapentin—epilepsy syndrome	7.52e-05	0.000192	CcSEcCtD
Cyproterone acetate—Nausea—Carbamazepine—epilepsy syndrome	7.51e-05	0.000191	CcSEcCtD
Cyproterone acetate—Constipation—Pregabalin—epilepsy syndrome	7.51e-05	0.000191	CcSEcCtD
Cyproterone acetate—Malaise—Topiramate—epilepsy syndrome	7.49e-05	0.000191	CcSEcCtD
Cyproterone acetate—Syncope—Topiramate—epilepsy syndrome	7.44e-05	0.00019	CcSEcCtD
Cyproterone acetate—Leukopenia—Topiramate—epilepsy syndrome	7.43e-05	0.000189	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	7.34e-05	0.00109	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Topiramate—epilepsy syndrome	7.3e-05	0.000186	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	7.29e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PFKL—epilepsy syndrome	7.26e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLCO1A2—epilepsy syndrome	7.26e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—KCNB1—epilepsy syndrome	7.26e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CACNA2D2—epilepsy syndrome	7.26e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC6A8—epilepsy syndrome	7.26e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—Nausea—Lamotrigine—epilepsy syndrome	7.26e-05	0.000185	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	7.26e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—Cough—Topiramate—epilepsy syndrome	7.24e-05	0.000185	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Pregabalin—epilepsy syndrome	7.24e-05	0.000184	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.18e-05	0.000183	CcSEcCtD
Cyproterone acetate—Dyspnoea—Gabapentin—epilepsy syndrome	7.18e-05	0.000183	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.16e-05	0.000182	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	7.1e-05	0.00106	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Gabapentin—epilepsy syndrome	7.09e-05	0.000181	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	7.06e-05	0.00105	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.02e-05	0.000179	CcSEcCtD
Cyproterone acetate—Decreased appetite—Gabapentin—epilepsy syndrome	7e-05	0.000178	CcSEcCtD
Cyproterone acetate—Discomfort—Topiramate—epilepsy syndrome	6.98e-05	0.000178	CcSEcCtD
Cyproterone acetate—Urticaria—Pregabalin—epilepsy syndrome	6.98e-05	0.000178	CcSEcCtD
Cyproterone acetate—Asthenia—Valproic Acid—epilepsy syndrome	6.97e-05	0.000178	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.95e-05	0.000177	CcSEcCtD
Cyproterone acetate—Fatigue—Gabapentin—epilepsy syndrome	6.94e-05	0.000177	CcSEcCtD
Cyproterone acetate—Abdominal pain—Pregabalin—epilepsy syndrome	6.94e-05	0.000177	CcSEcCtD
Cyproterone acetate—Body temperature increased—Pregabalin—epilepsy syndrome	6.94e-05	0.000177	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	6.93e-05	0.00103	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	6.91e-05	0.00103	CbGpPWpGaD
Cyproterone acetate—Constipation—Gabapentin—epilepsy syndrome	6.89e-05	0.000175	CcSEcCtD
Cyproterone acetate—Pruritus—Valproic Acid—epilepsy syndrome	6.87e-05	0.000175	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—SNRPE—epilepsy syndrome	6.78e-05	0.00101	CbGpPWpGaD
Cyproterone acetate—Oedema—Topiramate—epilepsy syndrome	6.78e-05	0.000173	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	6.68e-05	0.000993	CbGpPWpGaD
Cyproterone acetate—Shock—Topiramate—epilepsy syndrome	6.67e-05	0.00017	CcSEcCtD
Cyproterone acetate—Diarrhoea—Valproic Acid—epilepsy syndrome	6.65e-05	0.000169	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—UPB1—epilepsy syndrome	6.64e-05	0.000988	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NEU1—epilepsy syndrome	6.64e-05	0.000988	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ATIC—epilepsy syndrome	6.64e-05	0.000988	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Topiramate—epilepsy syndrome	6.64e-05	0.000169	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Gabapentin—epilepsy syndrome	6.64e-05	0.000169	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Topiramate—epilepsy syndrome	6.63e-05	0.000169	CcSEcCtD
Cyproterone acetate—Tachycardia—Topiramate—epilepsy syndrome	6.61e-05	0.000168	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EIF2B5—epilepsy syndrome	6.59e-05	0.000979	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.59e-05	0.000168	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	6.58e-05	0.000979	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Topiramate—epilepsy syndrome	6.58e-05	0.000168	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Topiramate—epilepsy syndrome	6.55e-05	0.000167	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	6.48e-05	0.000964	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Pregabalin—epilepsy syndrome	6.47e-05	0.000165	CcSEcCtD
Cyproterone acetate—Anorexia—Topiramate—epilepsy syndrome	6.46e-05	0.000165	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	6.43e-05	0.000956	CbGpPWpGaD
Cyproterone acetate—Dizziness—Valproic Acid—epilepsy syndrome	6.42e-05	0.000164	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	6.41e-05	0.000954	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—epilepsy syndrome	6.41e-05	0.000953	CbGpPWpGaD
Cyproterone acetate—Urticaria—Gabapentin—epilepsy syndrome	6.4e-05	0.000163	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—HSD17B4—epilepsy syndrome	6.4e-05	0.000951	CbGpPWpGaD
Cyproterone acetate—Body temperature increased—Gabapentin—epilepsy syndrome	6.37e-05	0.000162	CcSEcCtD
Cyproterone acetate—Abdominal pain—Gabapentin—epilepsy syndrome	6.37e-05	0.000162	CcSEcCtD
Cyproterone acetate—Hypotension—Topiramate—epilepsy syndrome	6.33e-05	0.000161	CcSEcCtD
Cyproterone acetate—Asthenia—Pregabalin—epilepsy syndrome	6.3e-05	0.000161	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—VDR—epilepsy syndrome	6.27e-05	0.000933	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	6.24e-05	0.000928	CbGpPWpGaD
Cyproterone acetate—Pruritus—Pregabalin—epilepsy syndrome	6.21e-05	0.000158	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GBE1—epilepsy syndrome	6.18e-05	0.000918	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPP1R3C—epilepsy syndrome	6.18e-05	0.000918	CbGpPWpGaD
Cyproterone acetate—Vomiting—Valproic Acid—epilepsy syndrome	6.18e-05	0.000157	CcSEcCtD
Cyproterone acetate—Rash—Valproic Acid—epilepsy syndrome	6.12e-05	0.000156	CcSEcCtD
Cyproterone acetate—Dermatitis—Valproic Acid—epilepsy syndrome	6.12e-05	0.000156	CcSEcCtD
Cyproterone acetate—Headache—Valproic Acid—epilepsy syndrome	6.09e-05	0.000155	CcSEcCtD
Cyproterone acetate—Dyspnoea—Topiramate—epilepsy syndrome	6.04e-05	0.000154	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.04e-05	0.000898	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Pregabalin—epilepsy syndrome	6.01e-05	0.000153	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—JUNB—epilepsy syndrome	6e-05	0.000892	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Topiramate—epilepsy syndrome	5.96e-05	0.000152	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—TFAM—epilepsy syndrome	5.96e-05	0.000885	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Gabapentin—epilepsy syndrome	5.93e-05	0.000151	CcSEcCtD
Cyproterone acetate—Decreased appetite—Topiramate—epilepsy syndrome	5.89e-05	0.00015	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.85e-05	0.000149	CcSEcCtD
Cyproterone acetate—Fatigue—Topiramate—epilepsy syndrome	5.84e-05	0.000149	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ASAH1—epilepsy syndrome	5.81e-05	0.000863	CbGpPWpGaD
Cyproterone acetate—Dizziness—Pregabalin—epilepsy syndrome	5.81e-05	0.000148	CcSEcCtD
Cyproterone acetate—Constipation—Topiramate—epilepsy syndrome	5.79e-05	0.000148	CcSEcCtD
Cyproterone acetate—Asthenia—Gabapentin—epilepsy syndrome	5.78e-05	0.000147	CcSEcCtD
Cyproterone acetate—Nausea—Valproic Acid—epilepsy syndrome	5.77e-05	0.000147	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	5.75e-05	0.000855	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	5.74e-05	0.000853	CbGpPWpGaD
Cyproterone acetate—Pruritus—Gabapentin—epilepsy syndrome	5.7e-05	0.000145	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	5.67e-05	0.000842	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—STXBP1—epilepsy syndrome	5.65e-05	0.00084	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR3C1—epilepsy syndrome	5.65e-05	0.00084	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	5.6e-05	0.000833	CbGpPWpGaD
Cyproterone acetate—Vomiting—Pregabalin—epilepsy syndrome	5.58e-05	0.000142	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Topiramate—epilepsy syndrome	5.58e-05	0.000142	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	5.57e-05	0.000828	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.54e-05	0.000141	CcSEcCtD
Cyproterone acetate—Rash—Pregabalin—epilepsy syndrome	5.54e-05	0.000141	CcSEcCtD
Cyproterone acetate—Dermatitis—Pregabalin—epilepsy syndrome	5.53e-05	0.000141	CcSEcCtD
Cyproterone acetate—Diarrhoea—Gabapentin—epilepsy syndrome	5.51e-05	0.00014	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—NT5E—epilepsy syndrome	5.51e-05	0.000819	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALAD—epilepsy syndrome	5.51e-05	0.000819	CbGpPWpGaD
Cyproterone acetate—Headache—Pregabalin—epilepsy syndrome	5.5e-05	0.00014	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	5.5e-05	0.000817	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	5.46e-05	0.000811	CbGpPWpGaD
Cyproterone acetate—Urticaria—Topiramate—epilepsy syndrome	5.38e-05	0.000137	CcSEcCtD
Cyproterone acetate—Abdominal pain—Topiramate—epilepsy syndrome	5.36e-05	0.000136	CcSEcCtD
Cyproterone acetate—Body temperature increased—Topiramate—epilepsy syndrome	5.36e-05	0.000136	CcSEcCtD
Cyproterone acetate—Dizziness—Gabapentin—epilepsy syndrome	5.33e-05	0.000136	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ALDH7A1—epilepsy syndrome	5.25e-05	0.000781	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CACNA1A—epilepsy syndrome	5.25e-05	0.000781	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	5.25e-05	0.00078	CbGpPWpGaD
Cyproterone acetate—Nausea—Pregabalin—epilepsy syndrome	5.22e-05	0.000133	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	5.19e-05	0.000772	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SNRPE—epilepsy syndrome	5.14e-05	0.000764	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ST3GAL3—epilepsy syndrome	5.14e-05	0.000764	CbGpPWpGaD
Cyproterone acetate—Vomiting—Gabapentin—epilepsy syndrome	5.12e-05	0.00013	CcSEcCtD
Cyproterone acetate—Rash—Gabapentin—epilepsy syndrome	5.08e-05	0.000129	CcSEcCtD
Cyproterone acetate—Dermatitis—Gabapentin—epilepsy syndrome	5.07e-05	0.000129	CcSEcCtD
Cyproterone acetate—Headache—Gabapentin—epilepsy syndrome	5.04e-05	0.000129	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ADSL—epilepsy syndrome	5.04e-05	0.000749	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Topiramate—epilepsy syndrome	4.99e-05	0.000127	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GLUL—epilepsy syndrome	4.94e-05	0.000734	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	4.87e-05	0.000724	CbGpPWpGaD
Cyproterone acetate—Asthenia—Topiramate—epilepsy syndrome	4.86e-05	0.000124	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CACNA1D—epilepsy syndrome	4.85e-05	0.000721	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—epilepsy syndrome	4.83e-05	0.000718	CbGpPWpGaD
Cyproterone acetate—Pruritus—Topiramate—epilepsy syndrome	4.79e-05	0.000122	CcSEcCtD
Cyproterone acetate—Nausea—Gabapentin—epilepsy syndrome	4.78e-05	0.000122	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—VDR—epilepsy syndrome	4.76e-05	0.000708	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—EIF2S1—epilepsy syndrome	4.73e-05	0.000703	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.68e-05	0.000695	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Topiramate—epilepsy syndrome	4.64e-05	0.000118	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—HSPB1—epilepsy syndrome	4.56e-05	0.000678	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TXNRD1—epilepsy syndrome	4.53e-05	0.000674	CbGpPWpGaD
Cyproterone acetate—Dizziness—Topiramate—epilepsy syndrome	4.48e-05	0.000114	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—AQP1—epilepsy syndrome	4.4e-05	0.000654	CbGpPWpGaD
Cyproterone acetate—Vomiting—Topiramate—epilepsy syndrome	4.31e-05	0.00011	CcSEcCtD
Cyproterone acetate—Rash—Topiramate—epilepsy syndrome	4.27e-05	0.000109	CcSEcCtD
Cyproterone acetate—Dermatitis—Topiramate—epilepsy syndrome	4.27e-05	0.000109	CcSEcCtD
Cyproterone acetate—Headache—Topiramate—epilepsy syndrome	4.24e-05	0.000108	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.23e-05	0.000629	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	4.2e-05	0.000625	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	4.17e-05	0.00062	CbGpPWpGaD
Cyproterone acetate—Nausea—Topiramate—epilepsy syndrome	4.02e-05	0.000103	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CHRM3—epilepsy syndrome	3.98e-05	0.000592	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—KCNJ11—epilepsy syndrome	3.98e-05	0.000592	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—JUNB—epilepsy syndrome	3.81e-05	0.000566	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.71e-05	0.000551	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.63e-05	0.00054	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	3.61e-05	0.000537	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—EIF2S1—epilepsy syndrome	3.59e-05	0.000533	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.48e-05	0.000518	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HSPB1—epilepsy syndrome	3.46e-05	0.000514	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCG2—epilepsy syndrome	3.24e-05	0.000482	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2C19—epilepsy syndrome	3.16e-05	0.00047	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP11A1—epilepsy syndrome	3.14e-05	0.000467	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.12e-05	0.000464	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SIRT1—epilepsy syndrome	3.06e-05	0.000456	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—VDR—epilepsy syndrome	3.02e-05	0.000449	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—JUNB—epilepsy syndrome	2.89e-05	0.000429	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—H2AFX—epilepsy syndrome	2.86e-05	0.000426	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.84e-05	0.000423	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2D6—epilepsy syndrome	2.84e-05	0.000422	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—YWHAZ—epilepsy syndrome	2.76e-05	0.000411	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR3C1—epilepsy syndrome	2.72e-05	0.000404	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADRA2A—epilepsy syndrome	2.7e-05	0.000401	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BCHE—epilepsy syndrome	2.69e-05	0.0004	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A1—epilepsy syndrome	2.56e-05	0.000381	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLCB1—epilepsy syndrome	2.54e-05	0.000377	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TH—epilepsy syndrome	2.53e-05	0.000376	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.49e-05	0.00037	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	2.33e-05	0.000346	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—VDR—epilepsy syndrome	2.29e-05	0.000341	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	2.17e-05	0.000323	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	2.11e-05	0.000314	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	2.1e-05	0.000312	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAT—epilepsy syndrome	2.08e-05	0.00031	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	2.03e-05	0.000301	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPX1—epilepsy syndrome	1.88e-05	0.00028	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AGT—epilepsy syndrome	1.65e-05	0.000245	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOE—epilepsy syndrome	1.62e-05	0.00024	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—POMC—epilepsy syndrome	1.39e-05	0.000207	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—epilepsy syndrome	1.27e-05	0.000188	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	1.11e-05	0.000165	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—epilepsy syndrome	8.33e-06	0.000124	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—epilepsy syndrome	6.32e-06	9.39e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—epilepsy syndrome	5.57e-06	8.28e-05	CbGpPWpGaD
